<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03313583</url>
  </required_header>
  <id_info>
    <org_study_id>EFS/2011/PopReceveur</org_study_id>
    <nct_id>NCT03313583</nct_id>
  </id_info>
  <brief_title>French One Day Survey in 2011 - Knowing Our Population of Labile Blood Products Recipients</brief_title>
  <acronym>PopReceveur</acronym>
  <official_title>French Transfusion Recipients Cross Sectional Study : Get to Know the Transfusion Recipients Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Etablissement Français du Sang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Région Nord-Pas de Calais, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Etablissement Français du Sang</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Describe the epidemiologic profile and clinical context of transfusion recipients in France.
      Describe the clinical context of transfusion.

      Describe the characteristics of the transfusion prescriptions, the use of blood products and
      the main indications for transfusion.

      Describe transfusion practice according the type of hospital stay.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2011</start_date>
  <completion_date type="Actual">December 1, 2011</completion_date>
  <primary_completion_date type="Actual">November 1, 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of red blood cell concentrates received</measure>
    <time_frame>1 day (cross sectional)</time_frame>
    <description>transversal study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of platelet concentrates recevied</measure>
    <time_frame>1 day (cross sectional)</time_frame>
    <description>transversal study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of plasma units received</measure>
    <time_frame>1 day (cross sectional)</time_frame>
    <description>transversal study</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">4720</enrollment>
  <condition>Blood Product Transfusion for All Conditions</condition>
  <condition>Trauma</condition>
  <condition>Surgical Blood Loss</condition>
  <condition>Hematologic Diseases</condition>
  <arm_group>
    <arm_group_label>Blood product recipients</arm_group_label>
    <description>All patients who received at least one blood product on the day of the study</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transfusion of blood products</intervention_name>
    <arm_group_label>Blood product recipients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        french population of recipients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • Transfusion with at least one blood product on the day of the study.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>All blood products recipients</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Fillet AM, Desmarets M, Assari S, Quaranta JF, François A, Pugin A, Schuhmacher A, Lassale B, Monnet E, Cabre P, Legrand D, Binda D, Djoudi R. Blood products use in France: a nationwide cross-sectional survey. Transfusion. 2016 Dec;56(12):3033-3041. doi: 10.1111/trf.13887. Epub 2016 Nov 2.</citation>
    <PMID>27807857</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2017</study_first_submitted>
  <study_first_submitted_qc>October 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2017</study_first_posted>
  <last_update_submitted>October 17, 2017</last_update_submitted>
  <last_update_submitted_qc>October 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematologic Diseases</mesh_term>
    <mesh_term>Blood Loss, Surgical</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

